IKAROVEC
Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
IKAROVEC
Industry:
Biotechnology Health Care Life Science
Founded:
2018-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
2.5 M GBP
Similar Organizations
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - Ikarovec
Future Planet Capital
Future Planet Capital investment in Seed Round - Ikarovec
LifeArc
LifeArc investment in Seed Round - Ikarovec
Parkwalk Advisors
Parkwalk Advisors investment in Seed Round - Ikarovec